A highly sensitive immuno-polymerase chain reaction assay for Clostridium botulinum neurotoxin type A

Toxicon

Volumn 43, Issue 1, 2004, Pages 27-34

  Chao, Hai Yuan ^a   Wang, Yeau Ching ^a   Tang, Shiao Shek ^a   Liu, Hwan Wun ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Clostridium botulinum neurotoxin type A; ELISA; Immuno PCR

Indexed keywords

BOTULINUM TOXIN A; DOUBLE STRANDED DNA; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; STREPTAVIDIN;

ACCURACY; ANTIBODY DETECTION; ARTICLE; BIOTINYLATION; CLOSTRIDIUM BOTULINUM; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; INTERMETHOD COMPARISON; NOISE REDUCTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REPORTER GENE; TECHNIQUE;

CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM;

EID: 1242314782     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2003.10.013     Document Type: Article

References (28)

1. Blasi J., Chapman E.R., Link E., Binz T., Yamasaki S., Decamilli P., Sudhof T.C., Niemann H., Jahn R. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature (London). 365:1993;160-163.
2. Blaustein R.O., Germann W.J., Finkelstein A., DasGupta B.R. The N-terminal half of the heavy chain of botulinum type A neurotoxin forms channels in planar phospholipid bilayers. FEBS Lett. 226:1987;115-120.
3. DasGupta B.R., Sathyamoorthy V. Purification and amino acid composition of type A botulinum neurotoxin. Toxicon. 22:1984;415-424.
4. Evans D.M., Williams R.S., Shone C.C., Hambleton P., Melling J., Dolly J.O. Botulinum neurotoxin type B. Its purification, radioiodination and interaction with rat-brain synaptosomal membranes. Eur. J. Biochem. 154:1986;409-416.
5. Gimenez J.A., Sugiyama H. Simplified purification method for Clostridium botulinum type E toxin. Appl. Environ. Microbiol. 53:1987;2827-2830.
6. Hendrickson E.R., Truby T.M., Joerger R.D., Majarian W.R., Ebersole R.C. High sensitivity multianalyte immunoassay using covalent DNA-labeled antibodies and polymerase chain reaction. Nucl. Acids Res. 23:1995;522-529.
7. Jankovic J. Medical therapy and botulinum toxin in dystonia. Adv. Neurol. 78:1998;169-183.
8. Joerger R.D., Truby T.M., Hendrickson E.R., Young R.M., Ebersole R.C. Analyte detection with DNA-labeled antibodies and polymerase chain reaction. Clin. Chem. 41:1995;1371-1377.
9. Kakizaki E., Yoshida T., Kawakami H., Oseto M., Sakai T., Sakai M. Detection of bacterial antigens using immuno-PCR. Lett. Appl. Microbiol. 23:1996;101-103.
10. Lopez del Val L.J., Morales Asin F. New applications of botulinum toxin. Neurolgia. 13:1995;388-394.
11. Maia M., Takahashi H., Adler K., Garlick R.K., Wands J.R. Development of a two-site immuno-PCR assay for hepatitis B surface antigen. J. Virol. Methods. 52:1995;273-286.
12. Mweene A.S., Ito T., Okazaki K., One E., Shimizu Y., Kida H. Development of immuno-PCR for diagnosis of bovine herpesvirus 1 infection. J. Clin. Microbiol. 34:1996;748-750.
13. Oguma K., Fujinaga Y., Inoue K. Structure and function of Clostridium botulinum toxins. Microbiol. Immunol. 39:1995;161-168.
14. Ren J., Chen Z., Juan S.J., Yong X.Y., Pan B.R., Fan D.M. Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno-polymerase chain reaction technique. Cancer. 88:2000;280-285.
15. Saito K., Kobayashi D., Sasaki M., Araake H., Kida T., Yagihashi A., Yajima T., Kameshima H., Watanabe N. Detection of human serum tumor necrosis factor-alpha in healthy donors, using a highly sensitive immuno-PCR assay. Clin. Chem. 45:1999;665-669.
16. Sanna P.P., Weiss F., Samson M.E., Bloom F.E., Pich E.M. Rapid induction of tumor necrosis factor alpha in the cerebrospinal fluid after intracerebroventricular injection of lipopolysaccharide revealed by a sensitive capture immuno-PCR assay. Proc. Natl Acad. Sci. USA. 92:1995;272-275.
17. Sano T., Smith C.L., Cantor C.R. Immuno-PCR: very sensitive antigen detection by means of specific antibody-DNA conjugates. Science. 258:1992;120-122.
18. Schiavo G., Rossetto O., Santucci A., DasGupta B.R., Montecucco C. Botulinum neurotoxins are zinc proteins. J. Biol. Chem. 267:1992;23479-23483.
19. Scott A.B., Kennedy R.A., Stubbs H.A. Botulinum A toxin injection as a treatment for blepharospasm. Arch. Ophthalmol. 103:1985;347-350.
20. 2-terminus of the heavy subunit of Clostridium botulinum type A neurotoxin forms channels in lipid vesicles. Eur. J. Biochem. 167:1987;175-180.
21. Simpson L.L. Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J. Pharmacol. Exp. Ther. 212:1980;16-21.
22. Simpson L.L. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol. Rev. 33:1981;155-188.
23. Simpson L.L. Molecular pharmacology of botulinum toxin and tetanus toxin. Annu. Rev. Pharmacol. Toxicol. 26:1986;427-453.
24. Syuto B., Kubo S. Separation and characterization of heavy and light chains from Clostridium botulinum type C toxin and their reconstitution. J. Biol. Chem. 256:1981;3712-3717.
25. Tse C.K., Dolly J.O., Hambleton P., Wray D., Melling J. Preparation and characterization of homogeneous neurotoxin type A from Clostridium botulinum. Its inhibitory action on neuronal release of acetylcholine in the absence and presence of beta-bungarotoxin. Eur. J. Biochem. 122:1982;493-500.
26. Tsui J.K. Botulinum toxin as a therapeutic agent. Pharmacol. Ther. 72:1996;13-24.
27. Whelan S.M., Elmore M.J., Bodsworth N.J., Brehm J.K., Atkinson T., Minton N.P. Molecular cloning of the Clostridium botulinum structural gene encoding the type B neurotoxin and determination of its entire nucleotide sequence. Appl. Environ. Microbiol. 58:1992;2345-2354.
28. Wu H.C., Huang Y.L., Lai S.C., Huang Y.Y., Shaio M.F. Detection of Clostridium botulinum neurotoxin type A using immuno-PCR. Lett. Appl. Microbiol. 32:2001;321-325.